ES2132891T3 - Procedimiento de preparacion de doxorrubicina. - Google Patents

Procedimiento de preparacion de doxorrubicina.

Info

Publication number
ES2132891T3
ES2132891T3 ES96904823T ES96904823T ES2132891T3 ES 2132891 T3 ES2132891 T3 ES 2132891T3 ES 96904823 T ES96904823 T ES 96904823T ES 96904823 T ES96904823 T ES 96904823T ES 2132891 T3 ES2132891 T3 ES 2132891T3
Authority
ES
Spain
Prior art keywords
doxorrubicin
preparation procedure
daunorubicin
doxorubicin
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96904823T
Other languages
English (en)
Inventor
Inventi Augusto Solari
Umberto Breme
Anna Luisa Colombo
Charles Richard Hutchinson
Sharee Otten
Claudio Scotti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Application granted granted Critical
Publication of ES2132891T3 publication Critical patent/ES2132891T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin

Abstract

LA CAPACIDAD DE CONVERTIR DAUNORUBICINA EN DOXORUBICINA PUEDE SER CONFERIDA EN UNA CELULA HUESPED MEDIANTE TRANSFORMACION CON UN VECTOR RECOMBINANTE QUE COMPRENDA ADN QUE CODIFIQUE 14HIDROXILASA DE DAUNORUBICINA. LA CELULA HUESPED PUEDE ENTONCES SER UTILIZADA PARA PRODUCIR DOXORUBICINA.
ES96904823T 1995-02-27 1996-02-20 Procedimiento de preparacion de doxorrubicina. Expired - Lifetime ES2132891T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/396,218 US5695966A (en) 1995-02-27 1995-02-27 DNA encoding daunorubicin 14-hyroxylase and method for preparing doxorubicin

Publications (1)

Publication Number Publication Date
ES2132891T3 true ES2132891T3 (es) 1999-08-16

Family

ID=23566340

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96904823T Expired - Lifetime ES2132891T3 (es) 1995-02-27 1996-02-20 Procedimiento de preparacion de doxorrubicina.

Country Status (19)

Country Link
US (2) US5695966A (es)
EP (1) EP0763112B1 (es)
JP (1) JPH10505506A (es)
KR (1) KR100414999B1 (es)
CN (1) CN1118574C (es)
AR (1) AR001014A1 (es)
AT (1) ATE178653T1 (es)
AU (1) AU711706B2 (es)
CA (1) CA2188571A1 (es)
DE (1) DE69601993T2 (es)
ES (1) ES2132891T3 (es)
FI (1) FI112251B (es)
HU (1) HU220530B1 (es)
IL (1) IL117246A0 (es)
NO (1) NO964482L (es)
RU (1) RU2205222C2 (es)
TW (1) TW419521B (es)
WO (1) WO1996027014A1 (es)
ZA (1) ZA961555B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695966A (en) * 1995-02-27 1997-12-09 Pharmacia & Upjohn S.P.A. DNA encoding daunorubicin 14-hyroxylase and method for preparing doxorubicin
US5976830A (en) * 1996-05-24 1999-11-02 The Ohio State University Research Foundation Methods of producing doxorubicin
GB2330144B (en) * 1997-03-06 2001-05-02 Pharmacia & Upjohn Spa Process for preparing doxorubicin
CA2326500A1 (en) * 1998-04-24 1999-11-04 Pharmacia & Upjohn S.P.A. Process for preparing doxorubicin
EP2392581A3 (en) * 2003-04-25 2012-03-07 North Carolina State University Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
WO2006111561A1 (en) * 2005-04-21 2006-10-26 Dsm Ip Assets B.V. Improved microbial production of anthracyclins
KR100629896B1 (ko) * 2005-04-28 2006-09-29 인하대학교 산학협력단 방선균 독소루비신 고생산 균주 및 독소루비신 생합성유전자군의 발현양상 분석을 위한 마이크로어레이칩
CN101016533B (zh) * 2005-11-09 2010-05-19 上海医药工业研究院 一种蒽环类抗生素产生工程菌及其应用
CN103087124B (zh) * 2012-11-21 2016-01-13 浙江海正药业股份有限公司 一种制备阿霉素的方法
CN104059892A (zh) * 2013-03-18 2014-09-24 江苏禾昌生物科技有限公司 柔红霉素c-14羟化酶突变体及其基因工程菌的生产方法
CN105861455B (zh) 2016-05-16 2018-10-26 浙江海正药业股份有限公司 DoxA蛋白突变体及其编码基因与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57159496A (en) * 1981-03-28 1982-10-01 Sanraku Inc Preparation of adriamycin
US5695966A (en) * 1995-02-27 1997-12-09 Pharmacia & Upjohn S.P.A. DNA encoding daunorubicin 14-hyroxylase and method for preparing doxorubicin
US5976830A (en) * 1996-05-24 1999-11-02 The Ohio State University Research Foundation Methods of producing doxorubicin

Also Published As

Publication number Publication date
AU711706B2 (en) 1999-10-21
KR970702922A (ko) 1997-06-10
CN1147835A (zh) 1997-04-16
ATE178653T1 (de) 1999-04-15
HUP9603259A2 (en) 1997-05-28
CA2188571A1 (en) 1996-09-06
FI964229A0 (fi) 1996-10-21
ZA961555B (en) 1996-08-19
AR001014A1 (es) 1997-08-27
IL117246A0 (en) 1996-06-18
MX9605018A (es) 1998-05-31
FI964229A (fi) 1996-10-21
WO1996027014A1 (en) 1996-09-06
US5786190A (en) 1998-07-28
EP0763112A1 (en) 1997-03-19
NO964482D0 (no) 1996-10-22
US5695966A (en) 1997-12-09
FI112251B (fi) 2003-11-14
TW419521B (en) 2001-01-21
RU2205222C2 (ru) 2003-05-27
HUP9603259A3 (en) 2000-04-28
EP0763112B1 (en) 1999-04-07
NO964482L (no) 1996-12-23
DE69601993D1 (de) 1999-05-12
HU220530B1 (hu) 2002-03-28
DE69601993T2 (de) 1999-11-04
AU4878496A (en) 1996-09-18
JPH10505506A (ja) 1998-06-02
KR100414999B1 (ko) 2004-04-28
CN1118574C (zh) 2003-08-20

Similar Documents

Publication Publication Date Title
CO4600681A1 (es) Composicion farmaceutica para la modulacion inmunitaria
NZ336829A (en) Adenoviruses having altered hexon proteins which present epitopes that are not recognised by neutralizing antibodies to the unmodified adenovirus of another serotype
MX206700B (es) Proceso para teñir fibras que contienen queratina.
DE69017809D1 (de) Transformatoren, insbesondere mit symmetrischer/unsymmetrischer Kopplung.
IT1295976B1 (it) Fermentatore da utilizzare, in particolare, nella industria enologica
ES2132891T3 (es) Procedimiento de preparacion de doxorrubicina.
DE69403985D1 (de) In Wasser dispergierte Harzzusammensetzung
DE3485229D1 (de) Shampoo-praeparate.
DE59506355D1 (de) Chromatographische isolierung von nucleinsäuren
DE69434384D1 (de) Metalkomplexbildner
MX9203852A (es) Composicion selladora acrilica mejorada, y metodos relacionados con la misma.
ITRM920411A1 (it) Procedimento per produrre glicosiltransferasi, vettore ibrido di lievito in esso impiegato e ceppo di lievito trasformato con impiego di vettore ibrido.
DE69423542D1 (de) Synthetisiertes, anorganisches Ionenaustauschermaterial sowie dieses enthaltende Waschmittelzusammensetzung
DE69403984T2 (de) In Wasser dispergierte Harzzusammensetzung
DE69108881D1 (de) Mechanismus zur Reduzierung von Druckverlusten in Rohrkrümmern.
Rousseau COSIMO I DE MEDICI AND ASTROLOGY: THE SYMBOLISM OF PROPHECY (ITALY)
DE69230997D1 (de) 4-0-methyl-transferas codierende DNA Sequenz
IT9067139A1 (it) Procedimento per convertire , lattoni alfa-acetil-sostituiti in lattoni alfa-alchiliden-sostituiti.
IT242850Y1 (it) Giostrina girevole manualmente,per pronosticare mediante i segni 1,x,2i risultati nelle schedine del totocalcio enalotto e totip con
IT226149Z2 (it) " una busta almeno parzialmente trasparente, da impiegare nelle autovetture per la esposizione di documenti ed altro, e per impieghi equivalenti " .
ITMI930465A1 (it) Gruppo di frenaggio perfezionato, in grado di aumentare l'azione di frenata.
RU97111129A (ru) Иммуностимулятор
ES2160005A1 (es) Tap0n de corcho perfeccionado.
ITPD960102A0 (it) Trabattello scomponibile e riducibile particolarmente per essere trasportato nel bagagliaio di una autovettura.
BR7200357U (pt) Disposicao construtiva em envelope

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 763112

Country of ref document: ES